Peritoneal Dialysis Market to Reach US$ 21.55 Billion by 2034 at a 7.17% CAGR

The Peritoneal Dialysis Market is experiencing significant growth as healthcare providers, hospitals, nephrology centers, and medical device manufacturers increasingly focus on effective renal replacement therapies for patients with kidney failure.

Market Overview

The peritoneal dialysis market was valued at US$ 11.56 billion in 2025 and is expected to reach US$ 21.55 billion by 2034; it is estimated to record a CAGR of 7.17% during 2026-2034.Peritoneal dialysis is a treatment that uses the peritoneum, the natural lining of the abdominal cavity, as a filter to remove waste products, excess fluids, and toxins from the blood. It is widely used for patients with end-stage renal disease (ESRD) and offers an alternative to conventional hemodialysis. Growing awareness of kidney health, increasing prevalence of chronic kidney disease, and rising preference for home-based dialysis treatments are supporting market expansion.

Download PDF Here: https://www.theinsightpartners.com/sample/TIPMD00002583

Key Market Drivers

The increasing prevalence of chronic kidney disease and end-stage renal disease is a major factor driving the Peritoneal Dialysis Market. Diabetes, hypertension, obesity, and other chronic health conditions contribute to kidney damage and increase the need for long-term renal replacement therapies. As the number of patients requiring dialysis continues to grow, healthcare providers are emphasizing accessible and convenient treatment options.

The growing preference for home-based healthcare is another important growth driver. Peritoneal dialysis allows eligible patients to perform treatment at home after appropriate training and medical guidance. This approach provides greater flexibility, reduces frequent hospital visits, and supports patient independence. Increasing investments in healthcare infrastructure and improvements in dialysis technology are further contributing to market development.

Peritoneal Dialysis Market Trends

Technological advancements in automated peritoneal dialysis (APD) systems are creating new opportunities for market participants. Modern dialysis machines offer improved treatment monitoring, programmable therapy schedules, and enhanced patient convenience. These developments are encouraging the adoption of automated solutions among patients and healthcare professionals.

Another emerging trend is the increasing integration of digital healthcare technologies into dialysis management. Remote patient monitoring, connected medical devices, and digital treatment management platforms are helping healthcare providers monitor treatment progress and identify potential complications. Manufacturers are also focusing on improving dialysis solutions, catheter designs, and related medical supplies to enhance treatment safety and effectiveness.

Peritoneal Dialysis Market Segmentation

The Peritoneal Dialysis Market can be segmented based on product type, treatment type, and end user.

By Product:

  • Peritoneal Dialysis Machines

  • Peritoneal Dialysis Solutions

  • Peritoneal Dialysis Catheters

  • Transfer Sets and Accessories

By Treatment Type:

  • Continuous Ambulatory Peritoneal Dialysis (CAPD)

  • Automated Peritoneal Dialysis (APD)

By End User:

  • Hospitals

  • Dialysis Centers

  • Home Care Settings

Among these segments, automated peritoneal dialysis is gaining attention due to its convenience and ability to provide scheduled treatments with minimal manual intervention. Home care settings also represent an important area of opportunity as healthcare systems increasingly encourage suitable patients to consider home-based dialysis.

Key Companies Operating in the Peritoneal Dialysis Market

The competitive landscape includes global medical technology companies and healthcare solution providers focusing on dialysis equipment, consumables, treatment solutions, and patient care services. Some prominent companies operating in the market include:

  • Baxter International Inc.

  • Fresenius Medical Care AG

  • B. Braun Melsungen AG

  • Medtronic plc

  • Nipro Corporation

  • Terumo Corporation

  • DaVita Inc.

  • JMS Co., Ltd.

  • Nikkiso Co., Ltd.

  • Cook Medical

These companies focus on product innovation, technological advancements, strategic collaborations, manufacturing expansion, and geographical development to strengthen their market positions. Continuous improvements in dialysis equipment and patient monitoring solutions are also shaping the competitive environment.

Regional Market Insights

North America represents an important region in the Peritoneal Dialysis Market due to its established healthcare infrastructure, growing awareness of home dialysis, and availability of advanced renal care technologies. The United States contributes significantly to regional demand through investments in kidney disease management and the adoption of innovative dialysis solutions.

Europe is also witnessing increasing demand for peritoneal dialysis, supported by an aging population, established healthcare systems, and growing efforts to improve access to renal replacement therapies. Meanwhile, Asia Pacific is expected to offer attractive growth opportunities due to the rising burden of diabetes and chronic kidney disease, expanding healthcare infrastructure, and improving access to dialysis services.

Future Outlook of the Peritoneal Dialysis Market

The future of the Peritoneal Dialysis Market is expected to remain promising as healthcare systems increasingly emphasize patient-centered kidney care, home-based treatment, and cost-effective renal replacement therapies. Advancements in automated dialysis machines, remote monitoring technologies, and improved dialysis consumables are likely to create new growth opportunities.

Related Reports

Dental Handpieces Market Drivers, Opportunities, Trends, and Forecasts by 2034

Ocular Drug Delivery Market Growth Opportunities and Forecast by 2028

About Us

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

Contact Person: Ankit Mathur
E-mail:ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish

Comments

Post a Comment

Popular posts from this blog

North America Potassium Gluconate Market Outlook: Health Awareness and Innovation Powering Market Expansion

Image
Potassium gluconate is a widely used mineral compound known for its role in maintaining electrolyte balance, supporting cardiovascular health, and promoting proper muscle and nerve function. It is extensively utilized in pharmaceuticals, dietary supplements, and fortified food products due to its high bioavailability and safety profile.  Potassium Gluconate Market Overview and Size Analysis The global potassium gluconate market size is projected to reach US$ 1,321.94 million by 2034 from US$ 686.52 million in 2025. The market is anticipated to register a CAGR of 7.55% during the forecast period 2026-2034. This robust growth is attributed to the rising prevalence of chronic diseases such as hypertension and cardiovascular disorders, coupled with increasing demand for dietary supplements. Additionally, the expansion of healthcare infrastructure and the growing focus on preventive care are contributing significantly to the growth of the potassium gluconate market. Download Sample Re...
Read more

Global Soybean Oil Pharma Grade Market Size to Reach US$ 2.46 Billion by 2034

The Soybean Oil Pharma Grade Market is experiencing significant growth as pharmaceutical manufacturers increasingly utilize high-purity soybean oil in drug formulations, parenteral nutrition products, vaccine adjuvants, and various pharmaceutical applications. Pharma-grade soybean oil is valued for its excellent biocompatibility, stability, and nutritional properties, making it a critical ingredient across the healthcare sector. The growing demand for advanced pharmaceutical products, expanding biologics manufacturing, and rising investments in healthcare infrastructure are contributing substantially to market expansion. Market Overview According to The Insight Partners, the soybean oil pharma grade market size is expected to reach US$ 2.46 billion by 2034 from US$ 1.38 billion in 2025 . The market is anticipated to register a CAGR of 6.63% during 2026–2034 . The increasing adoption of pharmaceutical excipients, expanding injectable drug production, and growing focus on patient nu...
Read more

Global Autoimmune Disease Therapeutics Market to Reach US$ 287.11 Billion by 2031: Key Growth Drivers

Autoimmune diseases represent a diverse group of chronic disorders in which the body’s immune system mistakenly attacks healthy tissues and organs. The increasing prevalence of autoimmune conditions, continuous advancements in biologics and targeted therapies, and growing awareness regarding early diagnosis have significantly transformed treatment approaches across the healthcare sector. Rising investments in research and development, expanding access to innovative medicines, and the integration of precision medicine continue to improve patient outcomes worldwide. As healthcare providers increasingly focus on personalized treatment strategies, the therapeutic landscape is evolving rapidly to address unmet clinical needs and improve long-term disease management. Industry Growth Supported by Innovative Therapeutic Developments The Autoimmune Disease Therapeutics Market size is expected to reach US$ 287.11 Billion by 2031. The market is anticipated to register a CAGR of 6.1% during 2025-2...
Read more